Jansen Burkhard 4
4 · DermTech, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Jansen Burkhard
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2019-12-31$12.40/sh−14,743$182,813→ 71,165 total - Exercise/Conversion
Common Stock
2019-12-31+47,541→ 85,908 total - Exercise/Conversion
Restricted Stock Units
2019-12-31−47,541→ 0 total→ Common Stock (47,541 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The shares of Issuer common stock underlying these restricted stock units have fully vested and were released to the reporting person on December 31, 2019.